Differential killing of pre-B acute lymphoblastic leukaemia cells by activated NK cells and the NK-92 ci cell line

Clinical and Experimental Immunology

Volumn 129, Issue 2, 2002, Pages 265-271

  Reid, G S D ^a   Bharya, S ^a   Klingemann, H G ^b   Schultz, K R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute lymphoblastic leukaemia; Cytotoxicity; NK 92; PI 3 kinase; TNF

Indexed keywords

INTERLEUKIN 2; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; HUMAN; HUMAN CELL; LYMPHATIC LEUKEMIA; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; KILLER CELLS, NATURAL; LEUKEMIA, PRE-B-CELL; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036381672     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01919.x     Document Type: Article

References (31)

1. Lanier LL. NK cell receptors. Annu Rev Immunol 1998; 16:359-93.
2. Shresta S, Pham CTN, Thomas DA, Graubert TA, Ley TJ. How do cytotoxic lymphocytes kill their targets? Curr Opin In Immunol 1998; 10:581-7.
3. Kashii Y, Giorda R, Herberman RB, Whiteside TL, Vujanovic NL. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J Immunol 1999; 163:5358-5366.
4. Gong JH, Maki G, Klingemann HG. Characterization of a human cell line (NK-92CI) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 1994; 8:652-8.
5. Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ. Antileukemia activity of a natural killer cell line against human leukemias. Clin Cancer Res 1998; 4:2859-68.
6. Tam YK, Miyagawa B, Ho VC, Klingemann HG. Immunotherapy of malignant melanoma in a SCID mouse model using the highly cytotoxic natural killer cell line 'NK-92CI. J Hematother 1999; 8:281-90.
7. Klingemann H-G, Wong E, Maki G. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood. Biol Blood Marrow Transplant 1996; 2:68-75.
8. Tonn T, Becker S, Esser R, Schwabe D, Seifried E. Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92. J Hematother Stem Cell Res 2001; 10:535-44.
9. Tam YK, Maki G, Miyagawa B, Tonn T, Klingemann HG. Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy. Hum General Ther 1999; 10:1359-73.
10. Reis LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR, eds. Cancer Incidence and Survival Among Children and Adolescents. United States SEER Program 1975-95. Bethesda: NCI, 1999. NIH pub. no. 99-4649.
11. Storkus WJ, Dawson JRB. Cell sensitivity to natural killing. Correlation with target cell stage of differentiation and state of activation. J Immunol 1986; 136:1542-7.
12. Maki G, Klingemann H-G, Martinson JA, Tam YT. Factors regulating the cytotxic activity of the human natural killer cell line, NK-92. J Hematother Stem Cell Res 2001; 10:369-83.
13. Kataoka T, Shinohara S, Takayama H, Takaku K, Kondo S, Yonehara S, Nagai K. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol 1996; 156:3678-86.
14. Johnsen AC, Haux J, Steinkjer B, Nonstad U, Egeberg K, Sundan A, Ashkenazi A, Espevik T. Regulation of APO-2 ligand/TRAIL expression in NK cells-involvement in NK cell-mediated cytotoxicity. Cytokine 1999; 11:664-72.
15. Alderson M, Tough TW, Braddy S, Davis-Smith T, Roux E, Schooley K, Miller RE, Lynch DH. Regulation of apoptosis and T cell activation by Fas-specific mAb. Int Immunol 1994; 6:1799-806.
16. Oka M, Hirazawa K, Yamamoto K, Iizuka N, Hazama S, Suzuki T, Kobayashi N. Induction of Fas-mediated apoptosis on circulating lymphocytes by surgical stress. Ann Surg 1996; 223:434-40.
17. Cifone MG, De Maria R, Roncaioli P, Rippo MR, Azuma M, Lanier LL, Santoni A, Testi R. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 1994; 180:1547-52.
18. Lanier LL. On guard - Activating NK cell receptors. Nat Immunol 2001; 2:23-7.
19. Jiang K, Zhong B, Gilvary DL, Corliss BC, Hong-Geller E, Wei S, Djeu JY. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cell. Nat Immunol 2001; 1:419-25.
20. Maki G, Krystal G, Dougherty G, Takei F, Klingemann HG. Induction of sensitivity to NK-mediated cytotoxicity by TNF-alpha treatment: Possible role of ICAM-3 and CD44. Leukemia 1998; 12:1565-72.
21. Ruggeri L, Capanni M. Casucci et al. Role of natural killer cell allore-activity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999; 94:333-9.
22. Colucci F, Schweighoffer E, Tomasello E, Turner M, Ortaldo JR, Vivier E, Tybulewicz VLJ, Di Santo JP. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nat Immunol 2002; 3:288-94.
23. Sconocchia G, Titus JA, Segal DM. Signaling pathways regulating CD44-dependent cytolysis in natyral killer cells. Blood 1997; 90:716-25.
24. Burshtyn DN, Biassoni R, Cantoni C et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intra-cellular domains. Immunity, 1995:77-85.
25. Peruzzi M, Wagtmann N, Long EO. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J Exp Med 1996; 184:1585-90.
26. Rajagopalan S, Long EO. A major histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 1999; 189:1093-9.
27. Wu J, Song Y, Bakker AB, Bauer S, Spies T, Lanier LL, Phillips JH. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999; 285:730-2.
28. Spaggiari GM, Carosio R, Pende D, Marcenaro S, Rivera P, Zocchi MR, Moretta L, Poggi A. NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phos-photidylinositol 3 kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp44. Eur J Immunol 2001; 31:1656-65.
29. Pende D, Cantoni C, Rivera P et al. Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol 2001; 31:1076-86.
30. Vitale M, Bottino C, Sivori S et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med 1998; 187:2065-72.
31. Droll A, Dougherty ST. Chiu RK, Dirks JF, McBride WH, Cooper DL, Dougherty GJ. Adhesive interactions between alternatively spliced CD44 isoforms. J Bio Chem 1995; 270:11567-73.